Abstract:The current proof-of-principle study was aimed toward development of a novel multidimensional protein identification technology (MudPIT) approach for the in-depth proteome analysis of human serum derived from patients with benign prostate hyperplasia (BPH) using rational chromatographic design principles. This study constituted an extension of our published work relating to the identification and relative quantification of potential clinical biomarkers in BPH and prostate cancer (PCa) tissue specimens. The proposed MudPIT approach encompassed the use of three distinct yet complementary liquid chromatographic chemistries. High-pressure size-exclusion chromatography (SEC) was used for the prefractionation of serum proteins followed by their dialysis exchange and solution phase trypsin proteolysis. The tryptic peptides were then subjected to offline zwitterion-ion hydrophilic interaction chromatography (ZIC-HILIC) fractionation followed by their online analysis with reversed-phase nano-ultraperformance chromatography (RP-nUPLC) hyphenated to nanoelectrospray ionization-tandem mass spectrometry using an ion trap mass analyzer. For the spectral processing, the sequential use of the SpectrumMill, Scaffold, and InsPecT software tools was applied for the tryptic peptide product ion MS(2) spectral processing, false discovery rate (FDR) assessment, validation, and protein identification. This milestone serum analysis study allowed the confident identification of over 1955 proteins (p ≤ 0.05; FDR ≤ 5%) with a broad spectrum of biological and physicochemical properties including secreted, tissue-specific proteins spanning approximately 12 orders of magnitude as they occur in their native abundance levels in the serum matrix. Also encompassed in this proteome was the confident identification of 375 phosphoproteins (p ≤ 0.05; FDR ≤ 5%) with potential importance to cancer biology. To demonstrate the performance characteristics of this novel MudPIT approach, a comparison was made with the proteomes resulting from the immunodepletion of the high abundant albumin and IgG proteins with offline first dimensional tryptic peptide separation with both ZIC-HILIC and strong cation exchange (SCX) chromatography and their subsequent online RP-nUPLC-nESI-MS(2) analysis.

Proteomic Analysis of Human Prostasomes.

Proteomics cataloging analysis of human expressed prostatic secretions reveals rich source of biomarker candidates.

Shotgun Proteomic Analysis of Microdissected Postmortem Human Pituitary Using Complementary Two-Dimensional Liquid Chromatography Coupled with Tandem Mass Spectrometer

Prostate Carcinoma Tissue Proteomics for Biomarker Discovery.

Proteomics of prostate cancer serum and plasma using low and high throughput approaches

Research of Differential Proteomics in Prostate Cancer by Two-Dimensional Polyacrylamide Gel Electrophoresis and Mass Spectrometry

Identification of a Specifically Expressed Modified Form of Novel PSP‐94 Protein in the Secretion of Benign Prostatic Hyperplasia

Multiproteases Combined with High-pH Reverse-Phase Separation Strategy Verified Fourteen Missing Proteins in Human Testis Tissue

A Comprehensive Guide for Performing Sample Preparation and Top-Down Protein Analysis

Proteomic Analysis of Prolactinoma Cells by Immuno-Laser Capture Microdissection Combined with Online Two-Dimensional Nano-Scale Liquid Chromatography/mass Spectrometry.

A prostate cancer tissue specific spectral library for targeted proteomic analysis

Comprehensive Analyses of Prostate Gene Expression: Convergence of Expressed Sequence Tag Databases, Transcript Profiling and Proteomics.

Proteomic analysis of murine testes lipid droplets

Identification of Candidate Prostate Cancer Biomarkers in Prostate Needle Biopsy Specimens Using Proteomic Analysis.

The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins

A proteomic approach to characterize protein shedding

Molecular Changes in Tissue Proteome during Prostate Cancer Development: Proof-of-Principle Investigation

Glycoproteomic Analysis of Human Urinary Exosomes

Comprehensive proteomic analysis of human pancreatic juice

Molecular Heterogeneity of Free PSA in Sera of Patients with Benign and Malignant Prostate Tumors